一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (382k)
Article in Japanese

Case Report

Successful treatment in a case of interstitial lung disease with clinically amyopathic dermatomyositis with positive anti-CADM-140/MDA5 antibodies by the administration of prednisolone, cyclosporin A, and mycophenolate mofetil

Kenjiro Shimaa  Takuro Sakagamia  Kosuke Ichikawaa  Satoshi Hokaria  Katsuaki Asakawaa  Toshiyuki Koyaa  Hiroshi Kagamua  Toshinori Takadab  Ichiei Naritaa 

aDivision of Respiratory Medicine, Department of Homeostatic Regulation and Development, Graduate School of Medical and Dental Sciences, Niigata University
bUonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital

ABSTRACT

A 29-year-old woman was admitted to Niigata University Medical and Dental Hospital. She was diagnosed as clinically amyopathic dermatomyositis (CADM), showing Gottron sign on fingers, telangiectasia around nails, less myogenic symptom, and positive anti-CADM-140/MDA5 antibodies. Also, a chest CT scan showed interstitial lung disease (ILD) as one of the comorbidities. She was treated with oral prednisolone, cyclosporin A, and mycophenolate mofetil (MMF). The treatment was well tolerated and induced improvement of the disease. A concentration of anti-CADM-140/MDA5 antibodies in serum was decreased. Although treatment for CADM-ILD has not been established, MMF might be one of the effective drugs for this disease.

KEYWORDS

Interstitial lung disease  Clinically amyopathic dermatomyositis  Anti-CADM-140/MDA5 antibodies  Mycophenolate mofetil 

Received 11 Jul 2014 / Accepted 8 Sep 2014

AJRS, 4(1): 76-80, 2015

Google Scholar